EU approves AstraZeneca's drug for adjunct use in Type-1 diabetes
British drugmaker AstraZeneca Plc said on Monday the European Commission approved its diabetes drug Forxiga for use as an oral supplement to insulin in adults with a rare type of the disease.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: AstraZeneca | Dapagliflozin | Diabetes | Diabetes Type 1 | Endocrinology | Forxiga | Health | Insulin | UK Health